Innovative biofibers made from a silk protein of the green lacewing are being developed at the Fraunhofer Institute for Applied Polymer Research IAP in conjunction with the company AMSilk GmbH. Researchers are working on producing the protein in large quantities by using biotechnology. The aim is to use the material in the future as a high-grade rigid fiber, for example, in lightweight plastics in transportation technology. It can also be conceivably used in medical technology, for example, as a biocompatible silk coating on implants. The Fraunhofer IAP is presenting its initial material sample at the International Green Week Berlin from January 20 to 29, 2017 in Hall 4.2, booth 212.
In order to protect their offspring from being eaten by predators near the ground, green lacewings deposit their eggs on the underside of leaves – on the ends of stable silk threads. These so-called egg stalks are only around 15 micrometers thick and can easily hold the weight of the eggs.
In order to produce these impressive fibers, the green lacewing excretes a protein secretion onto the leaf. The egg is then laid in the droplet and perpendicularly pulled out from the leaf. The resulting silk thread then hardens in the air.
»Unlike most other types of silk, the green lacewing’s egg stalk has a special structure with fascinating mechanical properties: green lacewing silk is extremely rigid and stable. We would like to transfer these special properties to fibers made from this silk. However, until now it has not been possible to produce this type of silk protein in sufficient quantities and purities, « explains Martin Schmidt, biotechnologist at the Fraunhofer IAP in Potsdam-Golm.
In a joint project with the company AMSilk GmbH, the researcher is working on manufacturing large amounts of green lacewing silk protein with the aid of bacteria using a biotech process. A team led by Professor Thomas Scheibel from the Chair of Biomaterials at the University of Bayreuth conducted the preliminary molecular-biological work. They constructed a special gene sequence which enables bacteria to produce the silk protein. Martin Schmidt is now optimizing the manufacturing process at the Fraunhofer IAP so that the silk protein can be produced inexpensively on an industrial scale. After this step it will be possible to develop the material.
AMSilk supports the project by conducting molecular biological work and by contributing its wide-ranging expertise in the field of silk analysis and production. The medium-sized company from Martinsried has been successfully developing silk-based biopolymers for various applications for years.
»We have been able to establish our silk technology and our first products are already available on the market. While the Biosteel® fiber we use is modeled after spider silk and is more soft and flexible, green lacewing silk is very rigid. This special property makes it interesting for medical technology and as a reinforcement fiber in lightweight engineering, for example in cars, airplanes or ships. We are pleased to be working in partnership with the Fraunhofer IAP, which is able to lend its expertise to this project in every area – from the development of the silk material to the finished fiber, « explains Dr. Lin Römer, scientific director of AMSilk. The project is being funded by the Agency for Renewable Resources (FNR), a project management organization of the Federal Ministry of Food and Agriculture.
For 25 years the Fraunhofer IAP has specialized in the development and characterization of fibers and fiber-reinforced composites for lightweight engineering and in the development of biobased polymers. At the institute’s own spinning plant, technical fibers can be manufactured on an industrial scale either from a solution or a melt. »Combining biotechnology and polymer research under one roof creates ideal conditions to produce fibers made from green lacewing silk. This is an enormous advantage for the development of innovative fields of application, « says Schmidt.
At the International Green Week Berlin from January 20 to 29, 2017 visitors to the trade fair nature.tec-Fachschau Bioökonomie in Hall 4.2 / booth 212 can survey the developments of the Fraunhofer IAP in the area of biotechnology and biopolymer research, including an initial material sample made from green lacewing silk.
Fraunhofer Institute for Applied Polymer Research IAP
The Fraunhofer IAP in Potsdam-Golm, Germany, specializes in research and development of polymer applications. It supports companies and partners in custom development and optimization of innovative and sustainable materials, processing aids and processes. In addition to the environmentally friendly, economical production, functionalization and processing of polymers in the laboratory and pilot plant scale, the institute also offers the characterization of polymers.
Synthetic petroleum-based polymers as well as biopolymers, polymers from renewable raw materials and chemically, physically or biologically functionalized polymers are in the focus of the institute’s work. The applications are diverse, ranging from biotechnology, medicine, pharmacy and cosmetics to electronics and optics as well as applications in the packaging, environmental and wastewater engineering or the aerospace, automotive, paper, construction and coatings industries. | Director: Prof. Dr. Alexander Böker
AMSilk GmbH is the world’s first industrial supplier of synthetic silk biopolymers and has its headquarters in Planegg near Munich, Germany. Sustainably produced using a patented biotechnological process, AMSilk high-performance biopolymers have the unique functional properties of the natural product they are based on. The organic high-performance material can be used in multiple ways, including in medical or technical products as well as cosmetic ingredients. AMSilk high-performance biopolymers give everyday products unique properties. Among other things, the polymers are biocompatible, breathable and especially robust.
AMSilk high-performance biopolymers are distributed in the form of Silkbeads (microparticles), Silkgel (hydrogel) or Biosteel® (fibers). They are currently used in coatings for medical technology products, in the textile industry and as an ingredient in personal care products.
Dr. Sandra Mehlhase | Fraunhofer-Institut für Angewandte Polymerforschung IAP
New megalibrary approach proves useful for the rapid discovery of new materials
19.12.2018 | Northwestern University
Artificial intelligence meets materials science
19.12.2018 | Texas A&M University
Different eras of civilization are defined by the discovery of new materials, as new materials drive new capabilities. And yet, identifying the best material...
Researchers from the University of Basel have reported a new method that allows the physical state of just a few atoms or molecules within a network to be controlled. It is based on the spontaneous self-organization of molecules into extensive networks with pores about one nanometer in size. In the journal ‘small’, the physicists reported on their investigations, which could be of particular importance for the development of new storage devices.
Around the world, researchers are attempting to shrink data storage devices to achieve as large a storage capacity in as small a space as possible. In almost...
The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.
Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...
What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.
The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...
12.12.2018 | Event News
10.12.2018 | Event News
06.12.2018 | Event News
19.12.2018 | Information Technology
19.12.2018 | Physics and Astronomy
19.12.2018 | Life Sciences